What Did the Research Discover? Researchers studied sacituzumab govitecan (SG) as a possible treatment for advanced endometrial cancer (EC) in patients who had already undergone chemotherapy and immunotherapy. The study was part of the TROPiCS-03 trial, which included patients with various metastatic solid tumors. In this phase II study, 41 patients with advanced EC...
For Immediate Release: March 28, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA’s Learning and Education to ADvance and Empower Rare Disease Drug Developers initiative published two new videos titled “Understanding the Importance of Endpoints in Rare Disease Drug Development”...
What did the research discover? This study explored whether high blood pressure (hypertension) and taking blood pressure medication in later life (ages 60 and older) affect the risk of developing dementia. Researchers analyzed data from 17 studies across 15 countries, including 34,519 older adults who did not have dementia at the start of the study. Participants...
What is Izervay prescribed for? Izervay is prescribed to treat geographic atrophy (GA) secondary to age-related macular degeneration. What is the name of the drug and what does it do? Izervay, pronounced EYE-ZER-VEY, (generic name: avacincaptad pegol) is a prescription medication approved for the treatment of geographic atrophy (GA), which is a...
What did the research discover? Recent data from the U.S. Centers for Disease Control and Prevention (CDC) shows a significant rise in whooping cough (also known as pertussis) cases. For the week ending September 14, 2024 there were 291 new cases were reported, with New York and Oklahoma experiencing the highest numbers. So far in 2024, the U.S. has recorded over...
What did the research discover? The U.S. Food and Drug Administration (FDA) has approved FluMist for self- or caregiver-administration. FluMist is a nasal spray vaccine that helps prevent the flu (influenza) in people aged 2 through 49. While FluMist has been around since 2003, it previously had to be administered by a healthcare provider. Now, it can be given by...